ANI Pharmaceuticals, Inc. (ANIP) Wins FDA OK for Everolimus Oral Suspension Generic

ANI Pharmaceuticals received FDA final approval for its ANDA for Everolimus Tablets for Oral Suspension (2mg, 3mg, 5mg), the generic of Afinitor Disperz. U.S. annual sales for the reference market are approximately $123M, per July 2026 IQVIA MAT.Material DetailsContext by AI AnalystThis is a mid-cy…